Nebivolol in the treatment of chronic heart failure

References

• A. Menarini Pharmaceuticals UK LtdNebilet 5 mg tablets: prescribing information (UK) [Online]2005 Accessed 26 November 2006. URL: http://emc.medicines.org.uk
   Google Scholar
• AstraZenecaLPToprol-XL (metoprolol succinate): prescribing information (USA) [online]2006 Accessed 25 March 2007. URL: http://www.astrazeneca-us.com/pi/toprol-xl.pdf
   Google Scholar
• BristowMRNelsonPMinobeWCharacterization of ±1-adrenergic receptor selectivity of nebivolol and various other beta-blockers in human myocardium [abstract]J Hypertens200518A512
   Web of Science ®Google Scholar
• BrixiusKBundkirchenABolckBNebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardiumBr J Pharmacol20011331330811498519
   PubMed Web of Science ®Google Scholar
• BowmanAJChenCPFordGANitric oxide mediated venodilator effects of nebivololBr J Clin Pharmacol1994381992047826820
   PubMed Web of Science ®Google Scholar
• BrehmBRWolfSCGornerSEffect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot studyEur J Heart Fail200247576312453547
   PubMed Web of Science ®Google Scholar
• CelikTLyisoyAKursakliogluHComparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patientsJ Hypertens200624591616467663
   PubMed Web of Science ®Google Scholar
• CheymolGWoestenborghRSnoeckEPharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjectsEur J Clin Pharmacol19975149389112066
   PubMed Web of Science ®Google Scholar
• CIBIS-II Investigators and CommitteesThe Cardiac Insufficiency Bisoprolol Study II (CIBIS-II)Lancet199935391310023943
   PubMed Web of Science ®Google Scholar
• CockcroftJRChowienczykPJBrettSENebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanismJ Pharmacol Exp Ther19953741067717562470
   PubMedGoogle Scholar
• CominaciniLPasiniAFGarbinUNebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivationJ Am Coll Cardiol20034218384414642697
   PubMed Web of Science ®Google Scholar
• CzurigaIRiecanskyIBodnarJComparison of new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the nebivolol, bisoprolol multicenter study (NEBIS)Cardiovasc Drugs Ther2003172576314574084
   PubMed Web of Science ®Google Scholar
• DessyCSaliezJGhisdalPEndothelial β3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation β-blocker nebivololCirculation2005112119820516116070
   PubMed Web of Science ®Google Scholar
• EdesIGasiorZWitaKEffects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA studyEur J Heart Fail20057631915921805
   PubMed Web of Science ®Google Scholar
• Eon Labs, Inc.Bisoprolol fumurate and hydrochlorothiazide tablets: prescribing information (USA)2004
   Google Scholar
• FlatherMDShibataMCCoatsAJSRandomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)Eur Heart J2005262152515642700
   PubMed Web of Science ®Google Scholar
• FogariRZoppiALazzariPComparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetesJ Hum Hypertens19971175379416986
   PubMed Web of Science ®Google Scholar
• FrishmanWHAlwarshettyMβ-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelinesClin Pharmacokinet2002415051612083978
   PubMed Web of Science ®Google Scholar
• GauthierCLeblaisVLesterKThe negative inotropic effect of β3-adrenoreceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricleJ Clin Invest19981021377849769330
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKlineCoreg (carvedilol): prescribing information (USA) [online]2007 Accessed 25 March 2007. URL: http://us.gsk.com/products/assets/us_coreg.pdf
   Google Scholar
• GosgnachWBoixelCNevoNNebivolol induces calcium-dependent signaling in endothelial cells by a possible β-adrenergic pathwayJ Cardiovasc Pharmacol200138191911483868
   PubMed Web of Science ®Google Scholar
• GrassiGTrevanoFGFacchiniAEfficacy and tolerability profile of nebivolol vs. atenolol in mild-moderate essential hypertension: a double-blind randomized multi-centre trialBlood Press Suppl20032354014761075
   PubMedGoogle Scholar
• HjalmarsonAGoldsteinSFagerbergBEffect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)Lancet19993532001710376614
   PubMed Web of Science ®Google Scholar
• HuntSAAbrahamWTChinMHACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) [online]2005 American College of Cardiology Website. URL: http://www.acc.org/clinical/guidelines/failure//index.pdf
   Google Scholar
• IgnarroLJExperimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation β-blockerBlood Press Suppl2004121615587107
   PubMedGoogle Scholar
• JanssenPMLZeitzORahmanAProtective role of nebivolol in hydroxyl radical induced injuryJ Cardiovasc Pharmacol200138Suppl 3S172311811388
   PubMedGoogle Scholar
• JessupMBrozenaSHeart failureN Engl J Med200334820071812748317
   PubMed Web of Science ®Google Scholar
• KalinowskiLDobruckiITMalinskiTRace-specific differences in endothelial function: predisposition of African Americans to vascular diseasesCirculation200410925111715159296
   PubMed Web of Science ®Google Scholar
• KamaliFHowesAThomasSHLA pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidineBr J Clin Pharmacol19974320149131955
   PubMed Web of Science ®Google Scholar
• KinlaySCreagerMAFukumotoMEndothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivoHypertension20013810495311711496
   PubMed Web of Science ®Google Scholar
• KomajdaMLapuertaPHermanNAdherence to guidelines is a predictor of outcome in chronic heart failure, the MAHLER surveyEur Heart J2005261653915827061
   PubMed Web of Science ®Google Scholar
• LawrenceTELiuSBlandTMSingle-dose pharmacokinetics and anticoagulant activity of warfarin is unaffected by nebivolol in healthy volunteers [abstract]Clin Pharmacol Ther2005a77P39
   Web of Science ®Google Scholar
• LawrenceTELiuSFisherJNo interaction between nebivolol and digoxin in healthy volunteers [abstract]Clin Pharmacol Ther2005b77P76
   PubMed Web of Science ®Google Scholar
• LawrenceTEChienCLiuSNo effect of concomitant administration of nebivolol and losartan in healthy volunteers genotyped for CYP2D6 status [abstract]Clin Pharmacol Ther2005c77P82
   Web of Science ®Google Scholar
• LawrenceTELiuSDonnellyCMA phase I open-label multiple dose study assessing the pharmacokinetic interaction of hydrochlorothiazide and nebivolol HCl in healthy volunteersAAPS PharmSci [online journal]20035 Abstract T2332. Accessed 30 November 2006. URL: http://www.aapsj.org/abstracts/am_abstracts2002.asp
   Google Scholar
• LefebvreJPoirierLPoirierPThe influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertensionBr J Clin Pharmacol2006 published online 10 November 2006
   PubMed Web of Science ®Google Scholar
• LekakisJPProtogerouAPapamichaelCEffect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery diseaseCardiovasc Drugs Ther2005192778116187009
   PubMed Web of Science ®Google Scholar
• LombardoRMRReinaCAbrignaniMGEffects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic functionAm J Cardiovasc Drugs200662596316913827
   PubMedGoogle Scholar
• McMurrayJCohen-SolalADietzRPractical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practiceEur J Heart Fail200577102116087129
   PubMed Web of Science ®Google Scholar
• MasonRPNitric oxide mechanisms in the pathogenesis of global riskJ Clin Hypertens200688 Suppl 2318
   Google Scholar
• MasonRPKalinowskiLJacobRFNebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of Black AmericansCirculation2005112379580116330685
   PubMed Web of Science ®Google Scholar
• MortonTTuHCLiuSA phase I open-label multiple-dose study of the pharmacokinetic interaction between nebivolol HCl and spironolactone in healthy volunteersAAPS PharmSci [online journal]20035 Abstract T2333. Accessed 30 November 2006. URL: http://www.aapsj.org/abstracts/am_abstracts2002.asp
   Google Scholar
• MoncadaSHiggsAThe L-arginine-nitric oxide pathwayN Engl J Med19933292002127504210
   PubMed Web of Science ®Google Scholar
• MortonTLLiuSPhillipsJMPharmacokinetics of nebivolol and ramipril are not affected by coadministration [abstract]Clin Pharmacol Ther200577P77
   Web of Science ®Google Scholar
• OpieLHCommerfordPJGershBJControversies in ventricular remodelingLancet20063673566716443044
   PubMed Web of Science ®Google Scholar
• PackerMBristowMRCohnJNThe effect of carvedilol on morbidity and mortality in patients with chronic heart failureN Engl J Med19963341349558614419
   PubMed Web of Science ®Google Scholar
• PackerMCoatsAJSFowlerMBEffect of carvedilol on survival in severe chronic heart failureN Engl J Med20013441651811386263
   PubMed Web of Science ®Google Scholar
• PasiniAFGarbinUNavaMCNebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivationJ Hypertens2005235899615716701
   PubMed Web of Science ®Google Scholar
• PanzaJAQuyyumiAABrushJEAbnormal endothelium-dependent vascular relaxation in patients with essential hypertensionN Engl J Med19903232272355955
   PubMed Web of Science ®Google Scholar
• PatrianakosAPParthenakisFIMavrakisHEComparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month studyAm Heart J2005150985e9e1816084141
   PubMedGoogle Scholar
• PesantYMarc-AureleJBielmannPMetabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-moderate hypertensionAm J Ther199961374710423656
   PubMedGoogle Scholar
• PeterPMartinUSharmaAEffect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertensionJ Clin Pharm Ther200631153916635049
   PubMed Web of Science ®Google Scholar
• PoirierLClerouxJNadeauAEffects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patientsJ Hypertens20011914293511518851
   PubMed Web of Science ®Google Scholar
• RizosEBairaktariEKostoulaAThe combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared with that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot studyJ Cardiovasc Pharmacol Ther200381273412808486
   PubMedGoogle Scholar
• ShawAABlandTMTuHCSingle-dose, relative bioavailability and food effect study of nebivolol hydrochloride in healthy volunteers characterized according to their metabolizing statusAAPS PharmSci [online journal]2003a5 Abstract W5238. Accessed 30 November 2006. URL: http://www.aapsj.org/abstracts/am_abstracts2002.asp
   Google Scholar
• ShawAABlandTMTuHCSingle-dose, dose-proportionality pharmacokinetic study of nebivolol hydrochloride in healthy volunteers characterized according to their metabolizing statusAAPS PharmSci [online journal]2003b5 Abstract M1327. Accessed 30 November 2006 URL: http://www.aapsj.org/abstracts/am_abstracts2002.asp
   Google Scholar
• ShawAALiuSZachwiejaLFEffect of chronic administration of fluoxetine on the pharmacokinetics of nebivolol [abstract]Clin Pharmacol Ther200577P38
   Web of Science ®Google Scholar
• SuleSSFrishmanWNebivolol: new therapy updateCardiol Rev2006142596416924166
   PubMedGoogle Scholar
• TaylorALZiescheSYancyCombination of isosorbide dinitrate and hydralazine in blacks with heart failureN Engl J Med200435120495715533851
   PubMed Web of Science ®Google Scholar
• TregaskisBFMcDevittDGβ-adrenoceptor-blocking drugs in the elderlyJ Cardiovasc Pharmacol199016Suppl 5S25S2811527132
   PubMedGoogle Scholar
• UhlirODvorakIGregorPNebivolol in the treatment of cardiac failure: a double-blind controlled clinical trialJ Card Fail1997327169547441
   PubMedGoogle Scholar
• The Menarini GroupClinical Trial Registry [online]2007 Accessed 2 April 2007 URL: http://www.menarini.com/english/clinical_trials/clinical_studies.htm
   Google Scholar
• SwedbergKClelandJDargieHGuidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005): the Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology [online]2005 Accessed 12 November 2006 URL: http://www.escardio.org/knowledge/guidelines/Chronic_Heart_Failure.htm
   Google Scholar
• TaylorALZiescheSYancyCCombination of isosorbide dinitrate and hydralazine in blacks with heart failureN Engl J Med200435120495715533851
   PubMed Web of Science ®Google Scholar
• Van BortelLMDe HoonJNKoolMJPharmacological properties of nebivolol in manEur J Clin Pharmacol199751379849049578
   PubMed Web of Science ®Google Scholar
• Van NeutenLDe CreeJNebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressureCardiovasc Drugs Ther199812339449825177
   PubMed Web of Science ®Google Scholar
• Van NeutenLTaylorFRRobertsonJISNebivolol vs. atenolol and placebo in essential hypertension: a double-blind randomized trialJ Hum Hypertens1213540
   PubMed Web of Science ®Google Scholar
• Van PeerASnoeckEWoestenborghsRClinical pharmacology of nebivolol. A reviewDrug Invest19913Suppl 12530
   Google Scholar
• VeverkaANuzumDSJollyJLNebivolol: a third-generation β-adrenergic blockerAnn Pharmacother20064013536016822893
   PubMed Web of Science ®Google Scholar